{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:22:23Z","timestamp":1774689743958,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,11,12]],"date-time":"2005-11-12T00:00:00Z","timestamp":1131753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00277-005-1099-0","type":"journal-article","created":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T13:11:48Z","timestamp":1124197908000},"page":"785-791","source":"Crossref","is-referenced-by-count":39,"title":["Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients"],"prefix":"10.1007","volume":"84","author":[{"given":"Ulrike","family":"Bacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Schnittger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Hiddemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,12]]},"reference":[{"key":"1099_CR1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2141.2001.02801.x","volume":"113","author":"MC Bene","year":"2001","unstructured":"Bene MC, Bernier M, Casasnovas RO, Castoldi G, Doekharan D, van der Holt B, Knapp W, Lemez P, Ludwig WD, Matutes E, Orfao A, Schoch C, Sperling C, van\u2019t Veer MB (2001) Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients. Br J Haematol 113:737\u2013745","journal-title":"Br J Haematol"},{"key":"1099_CR2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. French\u2013American\u2013British (FAB) co-operative group. Br J Haematol 33:451\u2013458","journal-title":"Br J Haematol"},{"key":"1099_CR3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia\u2014a report of the French\u2013American\u2013British Cooperative Group. Ann Intern Med 103:620\u2013625","journal-title":"Ann Intern Med"},{"key":"1099_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.1991.tb04444.x","volume":"78","author":"JM Bennett","year":"1991","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1991) Proposal for the recognition of minimally differentiated acute myeloid leukemia (Aml-Mo). Br J Haematol 78:325\u2013329","journal-title":"Br J Haematol"},{"key":"1099_CR5","first-page":"1","volume":"24","author":"CD Bloomfield","year":"1997","unstructured":"Bloomfield CD, Herzig GP, Caligiuri MA (1997) Introduction: acute leukemia: recent advances. Semin Oncol 24:1\u20132","journal-title":"Semin Oncol"},{"key":"1099_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/10428190009057633","volume":"37","author":"N Cascavilla","year":"2000","unstructured":"Cascavilla N, Melillo L, D\u2019arena G, Greco MM, Carella AM, Sajeva MR, Perla G, Matera R, Minervini MM, Carotenuto M (2000) Minimally differentiated acute myeloid leukemia (AML MO): clinico-biological findings of 29 cases. Leuk Lymphoma 37:105\u2013113","journal-title":"Leuk Lymphoma"},{"key":"1099_CR7","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","volume":"21","author":"BD Cheson","year":"2003","unstructured":"Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, Schiffer CA, Doekner H, Tallman MS, Lister TA, LoCocco F, Willemze R, Biondi A, Hiddemann W, Larson RA, Lowenberg B, Sanz MA, Head DR, Ohno R, Bloomfield CD (2003) Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 21:4642\u20134649","journal-title":"J Clin Oncol"},{"key":"1099_CR8","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1182\/blood.V85.12.3688.bloodjournal85123688","volume":"85","author":"A Cuneo","year":"1995","unstructured":"Cuneo A, Ferrant A, Michaux JL, Boogaerts M, Demuynck H, Vanorshoven A, Criel A, Stul M, Dalcin P, Hernandez J, Chatelain B, Doyen C, Louwagie A, Castoldi G, Cassiman JJ, Vandenberghe H (1995) Cytogenetic profile of minimally differentiated (Fab M0) acute myeloid leukemia\u2014correlation with clinicobiologic findings. Blood 85:3688\u20133694","journal-title":"Blood"},{"key":"1099_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/blood.V64.1.237.237","volume":"64","author":"J Cuttner","year":"1984","unstructured":"Cuttner J, Seremetis S, Najfeld V, Dimitriubona A, Winchester RA (1984) Tdt-positive acute leukemia with monocytoid characteristics\u2014clinical, cytochemical, cytogenetic, and immunological findings. Blood 64:237\u2013243","journal-title":"Blood"},{"key":"1099_CR10","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1200\/JCO.2002.09.088","volume":"20","author":"K Dohner","year":"2002","unstructured":"Dohner K, Tobis K, Ulrich R, Frohling S, Benner A, Schlenk RF, Dohner H (2002) Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the acute myeloid leukemia study group Ulm. J Clin Oncol 20:3254\u20133261","journal-title":"J Clin Oncol"},{"issue":"11","key":"1099_CR11","first-page":"49","volume":"44","author":"C Roumier","year":"2005","unstructured":"Roumier C, Eclache V, Imbert M, Davi F, MacIntyre E, Garand R, Talmant P, Lepelley P, Lai JL, Casasnovas O, Maynadie M, Mugneret F, Bilhou-Naberra C, Valensi F, Radford I, Mozziconacci MJ, Arnoulet C, Duchayne E, Dastugue N, Cornillet P, Daliphard S, Garnache F, Boudjerra N, Jouault H, Fenneteau O, Pedron B, Berger R, Flandrin G, Fenaux P, Preudhomme C, Groupe Francais de Cytogenetique Hematologique (GFCH), Groupe Francais d\u2019Hematologie Cellulaire (GFHC) (2005) Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Francais d\u2019Hematologie Cellulaire (GFHC). Leuk Lymphoma 44(11):49\u201358","journal-title":"Leuk Lymphoma"},{"key":"1099_CR12","first-page":"1041","volume":"21","author":"SS Farag","year":"2002","unstructured":"Farag SS, Archer KJ, Mrozek K, Vardiman JW, Carroll AJ, Pettenati MJ, Moore JO, Kolitz JE, Mayer RJ, Stone RM, Larson RA, Bloomfield CD (2002) Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Int J Oncol 21:1041\u20131051","journal-title":"Int J Oncol"},{"key":"1099_CR13","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/sj.leu.2402721","volume":"16","author":"D Grimwade","year":"2002","unstructured":"Grimwade D, Lo Coco F (2002) Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia. Leukemia 16:1959\u20131973","journal-title":"Leukemia"},{"key":"1099_CR14","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","volume":"92","author":"D Grimwade","year":"1998","unstructured":"Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92:2322\u20132333","journal-title":"Blood"},{"key":"1099_CR15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0145-2126(03)00076-6","volume":"27","author":"V Gupta","year":"2003","unstructured":"Gupta V, Minden MD, Yi QL, Brandwein J, Chun K (2003) Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia. Leuk Res 27:983\u2013991","journal-title":"Leuk Res"},{"key":"1099_CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/10428199609054825","volume":"23","author":"T Haferlach","year":"1996","unstructured":"Haferlach T, Bennett JM, Loffler H, Gassmann W, Andersen JW, Tuzuner N, Casslleth PA, Fonatsch C, Schoch C, Schlegelberger B, Becher R, Thiel E, Ludwig WD, Sauerland MC, Heinecke A, Buchner T (1996) Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. Leuk Lymphoma 23:227\u2013234","journal-title":"Leuk Lymphoma"},{"key":"1099_CR17","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1200\/JCO.2003.99.091","volume":"21","author":"T Haferlach","year":"2003","unstructured":"Haferlach T, Kern W, Schoch C, Hiddemann W, Sauerland MC (2003) Morphologic dysplasia in acute myeloid leukemia: importance of granulocytic dysplasia\u2014reply. J Clin Oncol 21:3004\u20133005","journal-title":"J Clin Oncol"},{"key":"1099_CR18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1365-2141.2002.03599.x","volume":"118","author":"T Haferlach","year":"2002","unstructured":"Haferlach T, Schoch C, Schnittger S, Kern W, Loffler H, Hiddemann W (2002) Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b): a study of 124 patients. Br J Haematol 118:426\u2013431","journal-title":"Br J Haematol"},{"key":"1099_CR19","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V87.6.2459.bloodjournal8762459","volume":"87","author":"T Haferlach","year":"1996","unstructured":"Haferlach T, Winkemann M, Loffler H, Schoch R, Gassmann W, Fonatsch C, Schoch C, Poetsch M, Weber Matthiesen K, Schlegelberger B (1996) The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May\u2013Grunwald\u2013Giemsa staining and fluorescence in situ hybridization. Blood 87:2459\u20132463","journal-title":"Blood"},{"key":"1099_CR20","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. J Clin Oncol 17:3835\u20133849","journal-title":"J Clin Oncol"},{"key":"1099_CR21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2141.1998.00714.x","volume":"101","author":"K Heinonen","year":"1998","unstructured":"Heinonen K, Mrozek K, Lawrence D, Arthur DC, Pettenati MJ, Stamberg J, Qumsiyeh MB, Verma RS, MacCallum J, Schiffer CA, Bloomfield CD (1998) Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study. Br J Haematol 101:513\u2013520","journal-title":"Br J Haematol"},{"key":"1099_CR22","volume-title":"Tumours of haematopoietic and lymphoid tissues","author":"E Jaffe","year":"2001","unstructured":"Jaffe E, Lee Harris (2001) Tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon"},{"key":"1099_CR23","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1182\/blood-2004-03-1036","volume":"104","author":"W Kern","year":"2004","unstructured":"Kern W, Voskova D, Schoch C, Hiddemann W, Schnittger S, Haferlach T (2004) Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia. Blood 104:3078\u20133085","journal-title":"Blood"},{"key":"1099_CR24","first-page":"528","volume":"89","author":"W Kern","year":"2004","unstructured":"Kern W, Voskova D, Schoch C, Schnittger S, Hiddemann W, Haferlach T (2004) Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia. Haematologica 89:528\u2013540","journal-title":"Haematologica"},{"key":"1099_CR25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cancergencyto.2004.03.008","volume":"155","author":"M Klaus","year":"2004","unstructured":"Klaus M, Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C (2004) Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cytogenet 155:47\u201356","journal-title":"Cancer Genet Cytogenet"},{"key":"1099_CR26","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V79.12.3325.bloodjournal79123325","volume":"79","author":"T Lion","year":"1992","unstructured":"Lion T, Haas OA, Harbott J, Bannier E, Ritterbach J, Jankovic M, Fink FM, Stojimirovic A, Herrmann J, Riehm HJ, Lampert F, Ritter J, Koch H, Gadner H (1992) The translocation T(1 22)(P13 Q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children. Blood 79:3325\u20133330","journal-title":"Blood"},{"key":"1099_CR27","volume-title":"Atlas of clinical hematology","author":"H Loeffler","year":"2005","unstructured":"Loeffler H, Raststetter J, Haferlach T (2005) Atlas of clinical hematology, 6th edn. Springer, Berlin Heidelberg New York","edition":"6"},{"key":"1099_CR28","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2004.03.023","volume":"22","author":"G Marcucci","year":"2004","unstructured":"Marcucci G, Mrozek K, Ruppert AS, Archer KJ, Pettenati MJ, Heerema NA, Carroll AJ, Koduru PRK, Kolitz JE, Sterling LJ, Edwards CG, Anastasi J, Larson RA, Bloomfield CD (2004) Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461. J Clin Oncol 22:2410\u20132418","journal-title":"J Clin Oncol"},{"key":"1099_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0609.1999.tb01728.x","volume":"62","author":"N Mauritzson","year":"1999","unstructured":"Mauritzson N, Johansson B, Albin M, Billstrom R, Ahlgren T, Mikoczy Z, Nilsson PG, Hagmar L, Mitelman F (1999) A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur J Haematol 62:95\u2013102","journal-title":"Eur J Haematol"},{"key":"1099_CR30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.1998.00760.x","volume":"101","author":"AB Mehta","year":"1998","unstructured":"Mehta AB, Bain BJ, Fitchett M, Shah S, Secker-Walker LM (1998) Trisomy 13 and myeloid malignancy\u2014characteristic blast cell morphology: a United Kingdom cancer cytogenetics group survey. Br J Haematol 101:749\u2013752","journal-title":"Br J Haematol"},{"key":"1099_CR31","unstructured":"Mitelman F (1995) An international system for human cytogenetic nomenclature. Karger"},{"issue":"2","key":"1099_CR32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-4608(00)00414-3","volume":"126","author":"AV Moorman","year":"2001","unstructured":"Moorman AV, Roman E, Willett EV, Dovey GJ, Cartwright RA, Morgan GJ (2001) Karyotype and age in acute myeloid leukemia. Are they linked? Cancer Genet Cytogenet 126(2):155\u2013161","journal-title":"Cancer Genet Cytogenet"},{"key":"1099_CR33","first-page":"17","volume":"24","author":"K Mrozek","year":"1997","unstructured":"Mrozek K, Heinonen K, delaChapelle A, Bloomfield CD (1997) Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 24:17\u201331","journal-title":"Semin Oncol"},{"key":"1099_CR34","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1182\/blood.V80.11.2873.2873","volume":"80","author":"OI Olopade","year":"1992","unstructured":"Olopade OI, Thangavelu M, Larson RA, Mick R, Kowalvern A, Schumacher HR, Lebeau MM, Vardiman JW, Rowley JD (1992) Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood 80:2873\u20132882","journal-title":"Blood"},{"key":"1099_CR35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood-2002-05-1474","volume":"101","author":"C Roumier","year":"2003","unstructured":"Roumier C, Eclache V, Imbert M, Davi F, Macintyre E, Garand R, Talmant P, Lepelley P, Lai JL, Casasnovas O, Maynadie M, Mugneret F, Bilhou-Naberra C, Valensi F, Radford I, Mozziconacci MJ, Arnoulet C, Duchayne E, Dastugue N, Cornillet P, Daliphard S, Garnache F, Boudjerra N, Jouault H, Fenneteau O, Pedron B, Berger R, Flandrin G, Fenaux P, Preudhomme C (2003) M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Francais d\u2019Hematologie Cellulaire (GFHC) and the Groupe Francais de Cytogenetique Hematologique (GFCH). Blood 101:1277\u20131283","journal-title":"Blood"},{"key":"1099_CR36","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood.V98.6.1746","volume":"98","author":"JF San Miguel","year":"2001","unstructured":"San Miguel JF, Vidriales MB, Lopez-Berges C, Diaz-Mediavilla J, Gutierrez N, Canizo C, Ramos F, Calmuntia MJ, Perez JJ, Gonzalez M, Orfao A (2001) Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification. Blood 98:1746\u20131751","journal-title":"Blood"},{"key":"1099_CR37","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.leu.2401773","volume":"14","author":"S Schnittger","year":"2000","unstructured":"Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T, Buchner T, Wormann B, Hiddemann W, Griesinger F (2000) Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 14:796\u2013804","journal-title":"Leukemia"},{"key":"1099_CR38","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1182\/blood-2003-03-0880","volume":"102","author":"S Schnittger","year":"2003","unstructured":"Schnittger S, Weisser M, Schoch C, Hiddemann W, Haferlach T, Kern W (2003) New score predicting for prognosis in PML\u2013RARA(+), AML1\u2013ETO+, or CBFB-MYH11(+) acute myeloid leukemia based on quantification of fusion transcripts. Blood 102:2746\u20132755","journal-title":"Blood"},{"issue":"3","key":"1099_CR39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/gcc.20193","volume":"43","author":"C Schoch","year":"2005","unstructured":"Schoch C, Kern W, Kohlmann A, Hiddemann W, Schnittger S, Haferlach T (2005) Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile. Genes Chromosomes Cancer 43(3):227\u2013238","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"1099_CR40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/gcc.10088","volume":"35","author":"C Schoch","year":"2000","unstructured":"Schoch C, Haferlach T, Bursch S, Kern W, Loeffler H, Hiddemann W (2000) Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH. Genes Chromosomes Cancer 35(1):20\u201329","journal-title":"Genes Chromosomes Cancer"},{"key":"1099_CR41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2141.1997.4473257.x","volume":"99","author":"C Schoch","year":"1997","unstructured":"Schoch C, Haase D, Fonatsch C, Haferlach T, Loffler H, Schlegelberger B, Hossfeld DK, Becher R, Sauerland MC, Heinecke A, Wormann B, Buchner T, Hiddemann W (1997) The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. Br J Haematol 99:605\u2013611","journal-title":"Br J Haematol"},{"key":"1099_CR42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11912-002-0032-0","volume":"4","author":"C Schoch","year":"2002","unstructured":"Schoch C, Haferlach T (2002) Cytogenetics in acute myeloid leukemia. Curr Oncol Rep 4:390\u2013397","journal-title":"Curr Oncol Rep"},{"key":"1099_CR43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2141.2001.02511.x","volume":"112","author":"C Schoch","year":"2001","unstructured":"Schoch C, Haferlach T, Haase D, Fonatsch C, Loffler H, Schlegelberger B, Staib P, Sauerland MC, Heinecke A, Buchner T, Hiddemann W (2001) Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients. Br J Haematol 112:118\u2013126","journal-title":"Br J Haematol"},{"key":"1099_CR44","first-page":"1082","volume":"89","author":"C Schoch","year":"2004","unstructured":"Schoch C, Kern W, Schnittger S, Buchner T, Hiddemann W, Haferlach T (2004) The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. Haematologica 89:1082\u20131090","journal-title":"Haematologica"},{"key":"1099_CR45","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2003-02-0434","volume":"102","author":"C Schoch","year":"2003","unstructured":"Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T (2003) AML with 11q23\/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 102:2395\u20132402","journal-title":"Blood"},{"issue":"1","key":"1099_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-4608(94)90174-0","volume":"73","author":"GJ Swansbury","year":"1994","unstructured":"Swansbury GJ, Lawler SD, Alimena G, Arthur D, Berger R, Van den Berghe H, Bloomfield CD, de la Chappelle A, Dewald G, Garson OM et al (1994) Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenet 73(1):1\u20137","journal-title":"Cancer Genet Cytogenet"},{"key":"1099_CR47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood.V89.2.621","volume":"89","author":"A Venditti","year":"1997","unstructured":"Venditti A, DelPoeta G, Buccisano F, Tamburini A, Cox MC, Stasi R, Bruno A, Aronica G, Maffei L, Suppo G, Simone MD, Forte L, Cordero V, Postorino M, Tufilli V, Isacchi G, Masi M, Papa G, Amadori S (1997) Minimally differentiated acute myeloid leukemia (AML-MO): comparison of 25 cases with other French\u2013American\u2013British subtypes. Blood 89:621\u2013629","journal-title":"Blood"},{"key":"1099_CR48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V100.1.29","volume":"100","author":"SR Wolman","year":"2002","unstructured":"Wolman SR, Gundacker H, Appelbaum FR, Slovak ML (2002) Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study. Blood 100:29\u201335","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-1099-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-005-1099-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-1099-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T01:53:19Z","timestamp":1586397199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-005-1099-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["1099"],"URL":"https:\/\/doi.org\/10.1007\/s00277-005-1099-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,12]]}}}